The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans
暂无分享,去创建一个
[1] Brent G. Nelson,et al. Frontal Hyperconnectivity Related to Discounting and Reversal Learning in Cocaine Subjects , 2011, Biological Psychiatry.
[2] S. Hyman,et al. Addiction, Dopamine, and the Molecular Mechanisms of Memory , 2000, Neuron.
[3] Patrick E. Rothwell,et al. Integrating synaptic plasticity and striatal circuit function in addiction , 2012, Current Opinion in Neurobiology.
[4] R K Siegel,et al. Cocaine hallucinations. , 1978, The American journal of psychiatry.
[5] B. Balleine,et al. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning , 2004, The European journal of neuroscience.
[6] K. Lynch,et al. Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. , 2012, Drug and alcohol dependence.
[7] E. Baca-García,et al. Executive dysfunction in chronic cocaine users: an exploratory study. , 2011, Drug and alcohol dependence.
[8] R. Sinha,et al. Immune system inflammation in cocaine dependent individuals: implications for medications development , 2012, Human psychopharmacology.
[9] Yihong Yang,et al. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity , 2010, NeuroImage.
[10] S. Hyman,et al. Acute Effects of Cocaine on Human Brain Activity and Emotion , 1997, Neuron.
[11] J. Javitch,et al. Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo* , 2009, Journal of Biological Chemistry.
[12] Hugh Garavan,et al. Executive Dysfunction in Cocaine Addiction: Evidence for Discordant Frontal, Cingulate, and Cerebellar Activity , 2004, The Journal of Neuroscience.
[13] G. Koob,et al. Extended access cocaine self‐administration differentially activates dorsal raphe and amygdala corticotropin‐releasing factor systems in rats , 2012, Addiction biology.
[14] A. Levey,et al. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users , 1996, Annals of neurology.
[15] Alan A. Wilson,et al. Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker? , 2008, The Journal of Neuroscience.
[16] Streichenwein Sm,et al. Am J Psychiatry , 1996 .
[17] K. Brady,et al. Impaired Cognitive Performance in Subjects with Methamphetamine Dependence during Exposure to Neutral versus Methamphetamine-Related Cues , 2012, The American journal of drug and alcohol abuse.
[18] M. Iyo,et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. , 2001, The American journal of psychiatry.
[19] I. Stolerman,et al. Drugs of abuse: behavioural principles, methods and terms. , 1992, Trends in pharmacological sciences.
[20] Andrea D Fass,et al. Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse , 2012, The Annals of pharmacotherapy.
[21] Peter W. Kalivas,et al. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[22] J. Cadet,et al. Methamphetamine Causes Microglial Activation in the Brains of Human Abusers , 2008, The Journal of Neuroscience.
[23] N. Volkow,et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers , 1993, Synapse.
[24] A. Sanjuán,et al. Right parietal hypoactivation in a cocaine-dependent group during a verbal working memory task , 2011, Brain Research.
[25] B. Rocha. Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice. , 2003, European journal of pharmacology.
[26] D. Sulzer,et al. How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission , 2011, Neuron.
[27] A. Kelley. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning , 2004, Neuroscience & Biobehavioral Reviews.
[28] T. Robbins,et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers , 2006, Psychopharmacology.
[29] S. Hyman,et al. Addiction and the brain: The neurobiology of compulsion and its persistence , 2001, Nature Reviews Neuroscience.
[30] J. D. McGaugh. Memory consolidation and the amygdala: a systems perspective , 2002, Trends in Neurosciences.
[31] R. Mattick,et al. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. , 2009, Addiction.
[32] Larry A. Kramer,et al. Diffusion Tensor Imaging and Decision Making in Cocaine Dependence , 2010, PloS one.
[33] Cheuk Y. Tang,et al. Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal , 1997, Neuropsychopharmacology.
[34] B. Everitt,et al. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex , 2002, Neuroscience & Biobehavioral Reviews.
[35] K. Berridge,et al. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.
[36] E. Vittinghoff,et al. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. , 2011, Archives of general psychiatry.
[37] Lian Zhang,et al. Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. , 2003, The American journal of psychiatry.
[38] Robinson Jb. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors: Enantiomers of amphetamine, n-methylamphetamine and deprenyl , 1985 .
[39] T. Robbins,et al. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion , 2005, Nature Neuroscience.
[40] L. Amato,et al. Antidepressants for cocaine dependence and problematic cocaine use. , 2011, The Cochrane database of systematic reviews.
[41] S. Sesack,et al. Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. , 2003, Annals of the New York Academy of Sciences.
[42] M. LaVoie,et al. Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.
[43] Lianne Schmaal,et al. N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study , 2012, Neuropsychopharmacology.
[44] S. Ross,et al. The Neurobiology of Addictive Disorders , 2009, Clinical neuropharmacology.
[45] R. A. Fuchs,et al. Subregion‐specific role of glutamate receptors in the nucleus accumbens on drug context‐induced reinstatement of cocaine‐seeking behavior in rats , 2012, Addiction biology.
[46] E. Cone,et al. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. , 2000, Journal of analytical toxicology.
[47] J. Lépine,et al. New treatments for cocaine dependence: a focused review. , 2008, The international journal of neuropsychopharmacology.
[48] Sara R. Jones,et al. Presynaptic dopamine modulation by stimulant self-administration. , 2013, Frontiers in bioscience.
[49] P. Kalivas,et al. N‐Acetyl Cysteine‐Induced Blockade of Cocaine‐Induced Reinstatement , 2003, Annals of the New York Academy of Sciences.
[50] W. Ling,et al. Medications development: successes and challenges. , 2005, Pharmacology & therapeutics.
[51] G. Koob. The role of CRF and CRF-related peptides in the dark side of addiction , 2010, Brain Research.
[52] S. Evans,et al. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. , 2007, Drug and alcohol dependence.
[53] Charles T. Taylor,et al. Combining computerized home-based treatments for generalized anxiety disorder: an attention modification program and cognitive behavioral therapy. , 2012, Behavior therapy.
[54] N. Fox,et al. Attention bias modification treatment for pediatric anxiety disorders: a randomized controlled trial. , 2012, The American journal of psychiatry.
[55] G. Di Chiara,et al. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[56] N. Volkow,et al. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. , 2000, Life sciences.
[57] David E. Moorman,et al. Lateral Hypothalamic Orexin/hypocretin Neurons: a Role in Reward-seeking and Addiction , 2009 .
[58] Ming D. Li,et al. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. , 2012, Addiction.
[59] G. Chiara,et al. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments , 1999, Neuroscience.
[60] Colleen A. Hanlon,et al. Elevated gray and white matter densities in cocaine abstainers compared to current users , 2011, Psychopharmacology.
[61] K. Berridge,et al. The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.
[62] B. Greenberg,et al. Anatomy and physiology of the basal ganglia: Implications for DBS in psychiatry , 2008, Neuroscience & Biobehavioral Reviews.
[63] M. Gold,et al. Neurobiology of tobacco smoking and other addictive disorders. , 1999, The Psychiatric clinics of North America.
[64] G. Bartzokis,et al. Choreoathetoid movements in cocaine dependence , 1999, Biological Psychiatry.
[65] K. Rice,et al. Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.
[66] Stephen J. Kish,et al. Pharmacologic mechanisms of crystal meth , 2008, Canadian Medical Association Journal.
[67] J. Bradshaw,et al. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control , 2010, Neuroscience & Biobehavioral Reviews.
[68] I. Grant,et al. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence , 2010, Journal of clinical and experimental neuropsychology.
[69] T. Robinson,et al. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.
[70] M. Kuhar,et al. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. , 1990, Life sciences.
[71] Samuel M. McClure,et al. A computational substrate for incentive salience , 2003, Trends in Neurosciences.
[72] G. Koob. Neural Mechanisms of Drug Reinforcement a , 1992, Annals of the New York Academy of Sciences.
[73] E. D. De Souza,et al. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. , 1991, The Journal of pharmacology and experimental therapeutics.
[74] E. Nestler,et al. Transcriptional and epigenetic mechanisms of addiction , 2011, Nature Reviews Neuroscience.
[75] C. Mathis,et al. In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers. , 2012, The American journal of psychiatry.
[76] Steven E. Hyman,et al. Revolution Stalled , 2012, Science Translational Medicine.
[77] Yiyun Huang,et al. Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior , 2004, Neuropsychopharmacology.
[78] Paul M. Thompson,et al. Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine , 2004, The Journal of Neuroscience.
[79] G F Koob,et al. Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.
[80] S. Hyman. Addiction: a disease of learning and memory. , 2005, The American journal of psychiatry.
[81] J. Cadet,et al. Methamphetamine toxicity and messengers of death , 2009, Brain Research Reviews.
[82] Rita Z. Goldstein,et al. Disrupted Functional Connectivity with Dopaminergic Midbrain in Cocaine Abusers , 2010, PloS one.
[83] J. Mariani,et al. Psychostimulant treatment of cocaine dependence. , 2012, The Psychiatric clinics of North America.
[84] T L Faber,et al. Neural activity related to drug craving in cocaine addiction. , 2001, Archives of general psychiatry.
[85] Colleen A. Hanlon,et al. Loss of laterality in chronic cocaine users: An fMRI investigation of sensorimotor control , 2010, Psychiatry Research: Neuroimaging.
[86] D. Ciccarone. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. , 2011, Primary care.
[87] P. Kalivas,et al. Drug Addiction as a Pathology of Staged Neuroplasticity , 2008, Neuropsychopharmacology.
[88] M. Höfler,et al. Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample , 2011, Acta psychiatrica Scandinavica.
[89] A. Waters,et al. Galantamine improves sustained attention in chronic cocaine users. , 2011, Experimental and clinical psychopharmacology.
[90] R. Wise. Action of drugs of abuse on brain reward systems , 1980, Pharmacology Biochemistry and Behavior.
[91] G. Rebec,et al. Lidocaine Inactivation of Ventral Subiculum Attenuates Cocaine-Seeking Behavior in Rats , 2003, The Journal of Neuroscience.
[92] R. Roth,et al. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract‐tracing study with Phaseolus vulgaris leucoagglutinin , 1989, The Journal of comparative neurology.
[93] K. Carroll,et al. Effects of galantamine on cocaine use in chronic cocaine users. , 2011, The American journal on addictions.
[94] E. Rolls. The representation of information about faces in the temporal and frontal lobes , 2007, Neuropsychologia.
[95] G. Rylander. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. , 1972, Psychiatria, neurologia, neurochirurgia.
[96] S. Purdon,et al. Predictors of psychosis severity in individuals with primary stimulant addictions. , 2011, Addictive behaviors.
[97] J. M. Ree,et al. Pharmacological treatments for heroin and cocaine addiction , 2003, European Neuropsychopharmacology.
[98] A. Dale,et al. Dorsal anterior cingulate cortex: A role in reward-based decision making , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[99] O. Kitamura. Detection of methamphetamine neurotoxicity in forensic autopsy cases. , 2009, Legal medicine.
[100] L. Amato,et al. Dopamine agonists for the treatment of cocaine dependence. , 2015, The Cochrane database of systematic reviews.
[101] R. See,et al. The neurocircuitry of addiction: an overview , 2008, British journal of pharmacology.
[102] F. Gawin. Cocaine abuse and addiction. , 1989, The Journal of family practice.
[103] S. Totterdell,et al. Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines , 2003, Brain Research.
[104] A. Smit,et al. The synaptic pathology of drug addiction. , 2012, Advances in experimental medicine and biology.
[105] R. North,et al. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. , 1992, The Journal of physiology.
[106] N. Uretsky,et al. The importance of calcium in the amphetamine-induced stimulation of dopamine synthesis in mouse striata in vivo. , 1982, The Journal of pharmacology and experimental therapeutics.
[107] S. Sesack,et al. Anatomical Substrates for Glutamate‐Dopamine Interactions , 2003 .
[108] Udi E. Ghitza,et al. Clonidine blocks stress-induced craving in cocaine users , 2011, Psychopharmacology.
[109] Reese T. Jones,et al. The bioavailability of intranasal and smoked methamphetamine , 2003, Clinical pharmacology and therapeutics.
[110] Walter Ling,et al. Bupropion for the Treatment of Methamphetamine Dependence , 2008, Neuropsychopharmacology.
[111] K. Berridge. Faculty Opinions recommendation of Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. , 2008 .
[112] T. Robbins,et al. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans , 2008, Psychopharmacology.
[113] M W Fischman,et al. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? , 1996, JAMA.
[114] A. Levey,et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.
[115] G. Uhl,et al. Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction , 2011, BMC Genomics.
[116] A. Mayer,et al. Enhanced cue reactivity and fronto-striatal functional connectivity in cocaine use disorders. , 2011, Drug and alcohol dependence.
[117] M. Witter,et al. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin , 1987, Neuroscience.
[118] K. Kantak,et al. Cognitive enhancers for facilitating drug cue extinction: Insights from animal models , 2011, Pharmacology Biochemistry and Behavior.
[119] Barry J. Everitt,et al. Psychomotor Stimulant Addiction: A Neural Systems Perspective , 2002, The Journal of Neuroscience.
[120] A. Copeland,et al. Differences between methamphetamine users and cocaine users in treatment. , 2001, Drug and alcohol dependence.
[121] Chris Cruickshank,et al. A review of the clinical pharmacology of methamphetamine. , 2009, Addiction.
[122] M. Banich,et al. Medial Orbitofrontal Cortex Gray Matter Is Reduced in Abstinent Substance-Dependent Individuals , 2009, Biological Psychiatry.
[123] P. Rucci,et al. Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study. , 2011, Current pharmaceutical design.
[124] A. Grace,et al. Amphetamine Activation of Hippocampal Drive of Mesolimbic Dopamine Neurons: A Mechanism of Behavioral Sensitization , 2008, The Journal of Neuroscience.
[125] S. Sesack,et al. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area , 1992, The Journal of comparative neurology.
[126] R. A. Fuchs,et al. Prefrontal cortical regulation of drug seeking in animal models of drug relapse. , 2010, Current topics in behavioral neurosciences.
[127] M. Le Moal,et al. Addiction and the brain antireward system. , 2008, Annual review of psychology.
[128] R. De La Garza,et al. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. , 2010, Gender medicine.
[129] S. Kubo,et al. Microglial and astrocytic changes in the striatum of methamphetamine abusers. , 2010, Legal medicine.
[130] A. Bentivoglio,et al. Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding. , 2008, Drug and alcohol dependence.
[131] S. Totterdell,et al. Individual nucleus accumbens-projection neurons receive both basolateral amygdala and ventral subicular afferents in rats , 2003, Neuroscience.
[132] W. van den Brink,et al. Pharmacological treatments for heroin and cocaine addiction. , 2003, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.
[133] M. Reivich,et al. Limbic activation during cue-induced cocaine craving. , 1999, The American journal of psychiatry.
[134] P. Kalivas. The glutamate homeostasis hypothesis of addiction , 2009, Nature Reviews Neuroscience.
[135] W. Ling,et al. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. , 2010, Drug and alcohol dependence.
[136] P. Kalivas,et al. Is cocaine desire reduced by N-acetylcysteine? , 2007, The American journal of psychiatry.
[137] R. Wise,et al. Cocaine Experience Establishes Control of Midbrain Glutamate and Dopamine by Corticotropin-Releasing Factor: A Role in Stress-Induced Relapse to Drug Seeking , 2005, The Journal of Neuroscience.
[138] T. Rubino,et al. The role of the endogenous cannabinoid system in drug addiction. , 2008, Drug news & perspectives.
[139] P. Clarke,et al. Segregation of Amphetamine Reward and Locomotor Stimulation between Nucleus Accumbens Medial Shell and Core , 2003, The Journal of Neuroscience.
[140] Diana Martinez,et al. Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature , 2008, Synapse.
[141] I. Grant,et al. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. , 2005, Neuropsychology.
[142] Gregory V. Simpson,et al. Computerized Cognitive Training Restores Neural Activity within the Reality Monitoring Network in Schizophrenia , 2012, Neuron.
[143] C. Drenzek,et al. Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections , 2007, Emerging infectious diseases.
[144] T. Robbins,et al. Dopamine Release in the Dorsal Striatum during Cocaine-Seeking Behavior under the Control of a Drug-Associated Cue , 2002, The Journal of Neuroscience.
[145] N. Volkow,et al. The neural basis of addiction: a pathology of motivation and choice. , 2005, The American journal of psychiatry.
[146] G. Rudnick,et al. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. , 1993, Biochimica et biophysica acta.
[147] G. C. Wagner,et al. Methamphetamine-induced neuronal damage: A possible role for free radicals , 1989, Neuropharmacology.
[148] J. Samet,et al. Food and Drug Administration , 2007, BMJ : British Medical Journal.
[149] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[150] R. A. Fuchs,et al. Effects of mGluR1 antagonism in the dorsal hippocampus on drug context-induced reinstatement of cocaine-seeking behavior in rats , 2009, Psychopharmacology.
[151] C. Roncero,et al. Efficacy of psychostimulant drugs for cocaine dependence. , 2010, The Cochrane database of systematic reviews.
[152] D. Nichols,et al. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. , 1986, Journal of psychoactive drugs.
[153] N. Volkow,et al. Addiction: Beyond dopamine reward circuitry , 2011, Proceedings of the National Academy of Sciences.
[154] Mark Slifstein,et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. , 2007, The American journal of psychiatry.
[155] D. Sibley,et al. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. , 2012, Biochemical pharmacology.
[156] R. Gainetdinov,et al. Cocaine self-administration in dopamine-transporter knockout mice , 1998, Nature Neuroscience.
[157] A. Waters,et al. Cognitive enhancement as a treatment for drug addictions , 2013, Neuropharmacology.
[158] R. Wightman,et al. Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.
[159] H. Fibiger,et al. Feeding-evoked dopamine release in the nucleus accumbens: regulation by glutamatergic mechanisms , 1997, Neuroscience.
[160] P. Kalivas,et al. Cystine/glutamate exchange serves as the source for extracellular glutamate: Modifications by repeated cocaine administration , 2002, Amino Acids.
[161] D. Rusyniak. Neurologic manifestations of chronic methamphetamine abuse. , 2011, Neurologic clinics.
[162] R. Vertes,et al. Nucleus reuniens of the midline thalamus: Link between the medial prefrontal cortex and the hippocampus , 2007, Brain Research Bulletin.
[163] R. Wise. Dopamine and reward: The anhedonia hypothesis 30 years on , 2008, Neurotoxicity Research.
[164] T. Robbins,et al. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[165] M. Sofuoglu,et al. Cognitive enhancement as a pharmacotherapy target for stimulant addiction. , 2010, Addiction.
[166] K. Berridge,et al. The Mind of an Addicted Brain: Neural Sensitization of Wanting Versus Liking , 1995 .
[167] G. Bartzokis,et al. White-matter abnormalities in brain during early abstinence from methamphetamine abuse , 2010, Psychopharmacology.
[168] N. Volkow,et al. Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence , 2001, The Journal of Neuroscience.
[169] L. Jarrard. What does the hippocampus really do? , 1995, Behavioural Brain Research.
[170] D. Mash,et al. Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims , 1997, Brain Research.
[171] W. Hall,et al. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. , 1997, Drug and alcohol dependence.
[172] G. Aston-Jones,et al. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats , 2012, Psychopharmacology.
[173] L. Parsons,et al. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. , 2011, Pharmacology & therapeutics.
[174] K. Gysling. Relevance of both type-1 and type-2 corticotropin releasing factor receptors in stress-induced relapse to cocaine seeking behaviour. , 2012, Biochemical pharmacology.
[175] J S Fowler,et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. , 2001, The American journal of psychiatry.
[176] George Bartzokis,et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research , 2000, Psychiatry Research: Neuroimaging.
[177] D. Sulzer,et al. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[178] T. Robbins,et al. The basolateral amygdala-ventral striatal system and conditioned place preference: Further evidence of limbic-striatal interactions underlying reward-related processes , 1991, Neuroscience.
[179] E. Butelman,et al. Pharmacotherapy of addictions , 2002, Nature Reviews Drug Discovery.
[180] D. Kuhn,et al. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines , 2004, Neuroscience Letters.
[181] B. Rounsaville,et al. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. , 2010, The American journal on addictions.
[182] K. J. Rhee,et al. Choreoathetoid disorder associated with amphetamine-like drugs. , 1988, The American journal of emergency medicine.
[183] M. Iyo,et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. , 2003, The American journal of psychiatry.
[184] J. Kleinman,et al. Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. , 1994, The American journal of psychiatry.
[185] R. Wise,et al. Brain dopamine and reward. , 1989, Annual review of psychology.
[186] T. Kosten,et al. Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine , 2009, The American journal of drug and alcohol abuse.
[187] I. Grant,et al. Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval , 2012, The Australian and New Zealand journal of psychiatry.
[188] M. Haney,et al. Aripiprazole maintenance increases smoked cocaine self-administration in humans , 2011, Psychopharmacology.
[189] Y. Shaham,et al. Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review , 2002, Pharmacological Reviews.
[190] B. Everitt,et al. Dissociable Effects of Antagonism of NMDA and AMPA/KA Receptors in the Nucleus Accumbens Core and Shell on Cocaine-seeking Behavior , 2001, Neuropsychopharmacology.
[191] J. Loftis,et al. Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report , 2011, Neurotoxicity Research.
[192] J S Fowler,et al. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. , 2001, The American journal of psychiatry.
[193] M. Preiss,et al. Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers. , 2012, Psychiatria Danubina.
[194] R. Sunahara,et al. Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction. , 2012, Future medicinal chemistry.
[195] D. Sulzer,et al. Methamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis , 2002, The Journal of Neuroscience.
[196] A. Cho,et al. Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. , 1995, The Journal of pharmacology and experimental therapeutics.
[197] L. Swanson,et al. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems , 2001, Brain Research Reviews.
[198] T. Jay. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms , 2003, Progress in Neurobiology.
[199] A. Grace,et al. Dopamine-Dependent Interactions between Limbic and Prefrontal Cortical Plasticity in the Nucleus Accumbens: Disruption by Cocaine Sensitization , 2005, Neuron.
[200] A Kübler,et al. Cocaine dependence and attention switching within and between verbal and visuospatial working memory , 2005, The European journal of neuroscience.
[201] Daniele Lecca,et al. Dopamine and drug addiction: the nucleus accumbens shell connection , 2004, Neuropharmacology.
[202] M. Álvaro-Bartolomé,et al. Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats , 2011, Neuroscience.
[203] Yongmin Chang,et al. Impairments of facial emotion recognition and theory of mind in methamphetamine abusers , 2011, Psychiatry Research.
[204] T. Kosten,et al. Immunotherapy for drug abuse. , 2011, CNS & neurological disorders drug targets.
[205] T. Insel. Next-Generation Treatments for Mental Disorders , 2012, Science Translational Medicine.
[206] S. J. Gatley,et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects , 1997, Nature.
[207] Y. Shaham,et al. The reinstatement model of drug relapse: history, methodology and major findings , 2003, Psychopharmacology.
[208] T. Robbins,et al. Differential control over cocaine-seeking behavior by nucleus accumbens core and shell , 2004, Nature Neuroscience.
[209] Michael H. Buonocore,et al. Cognitive Control and White Matter Callosal Microstructure in Methamphetamine-Dependent Subjects: A Diffusion Tensor Imaging Study , 2009, Biological Psychiatry.
[210] Rajita Sinha,et al. Chronic Stress, Drug Use, and Vulnerability to Addiction , 2008, Annals of the New York Academy of Sciences.
[211] D. Sulzer,et al. Mechanisms of neurotransmitter release by amphetamines: A review , 2005, Progress in Neurobiology.
[212] J. B. Robinson. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl. , 1985, Biochemical pharmacology.
[213] D. Ciraulo,et al. Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned. , 2005, Addiction.
[214] A. Minassian,et al. Effect of methamphetamine dependence on everyday functional ability. , 2010, Addictive behaviors.